The Icahn School of Medicine at Mount Sinai is committed to innovative research and partnering with industry to develop innovative therapies and diagnostics that improve the lives of patients worldwide. Mount Sinai Innovation Partners (MSIP) facilitates the real-world application and commercialization of Mount Sinai discoveries and the development of research partnerships with industry.
What is technology transfer?
This term refers to the process of formally transferring usage or commercialization rights on new discoveries, inventions, or innovations, from scientific research to another party. Typically, it involves copyright or patent protection, followed by licensing to an identified partner, as described in the Innovation Guide.
What are the benefits of academic technology transfer?
Academic technology transfer involves the licensing of innovations by universities, teaching hospitals, research institutes, and patent management firms to the commercial sector. This transfer adds billions of dollars to the U.S. economy and supports hundreds of thousands of jobs. In addition, it helps generate new businesses, industries, and markets. Most important, it leads to the development of products and services that improve our quality of life.